Table 1.
Study | Number of cases | Population size | Study end points | Major findings |
---|---|---|---|---|
Xu et al. [17] | (i) 9 cross-sectional studies, 9 case-control studies, and 6 cohort studies | (i) 10191 study subjects including adults and children | (i) HAdV-36 infection rate in obese and lean groups (ii) BMI level and BMI z-score in HAdV-36 positive and negative groups |
(i) HAdV-36 infection increased the risk of obesity (ii) HAdV-36 also increased the risk of weight gain in adults, which was not observed in children |
| ||||
Shang et al. [18] | (i) 11 case control studies | (i) 5739 study subjects including adults and children | (i) HAdV-36 infection and obesity risk | (i) HAdV-36 infection is associated with an increased risk of obesity development (ii) Risk is increased in children and those with a BMI of ≥30 kg/cm2 |
| ||||
Yamada et al. [19] | (i) 10 cross-sectional studies | (i) 2870 study subjects including adults and children | (i) Evaluating the association between HAdV-36 infection and obesity/metabolic markers | (i) HAdV-36 infection is associated with the risk of obesity and weight gain, but not with abnormal metabolic markers including waist circumference |